4.4 Review

Reprocessing Effectiveness for Flexible Ureteroscopes: A Critical Look at the Evidence

期刊

UROLOGY
卷 164, 期 -, 页码 25-32

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2022.01.03325

关键词

-

资金

  1. Boston Scientific Corporation (BSC)
  2. 3M Company
  3. Ambu
  4. Auris Health
  5. Advanced Sterilization Products
  6. Cantel/Medivators
  7. Convergascent
  8. Fortive
  9. Healthmark
  10. Laborie/Cogentix
  11. Pentax
  12. Steris

向作者/读者索取更多资源

Flexible ureteroscopes are essential devices but the reprocessing process is complex and poses risks to patient safety.
Flexible ureteroscopes are essential devices, and reusable models require meticulous cleaning and sterilization between procedures. Reprocessing is complex, time-consuming, and difficult due to the instrument's small size, fragility, and internal channel. The Food and Drug Administration recently raised concerns about the effectiveness of ureteroscope reprocessing. Due to inadequate reprocessing and maintenance, contaminated and damaged ureteroscopes pose risks to patient safety. This review describes ureteroscope reprocessing methods and summarizes evidence on reprocessing effectiveness and documented outcomes associated with the use of damaged or inadequately cleaned and sterilized ureteroscopes. (C) 2022 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据